The purpose of this site is to help share information about the financial markets to all investors.
Stocks, bonds, mutual funds, options, etfs, savings accounts, and interest rates will be the main topics of discussion.
Friday, October 06, 2006
Drugs & Biotech
After the bell Johnson & Johnson (JNJ) reported positive news about the use of Risperdal for autism. If you are looking for speculation in biotech take a look at NeoPharm (NEOL) and Nabi Biopharmaceuticals (NABI).
As of 10/6/06 I have no position in any of the above stocks.
0 Comments:
Post a Comment
<< Home